Fludarabine therapy in Waldenström's macroglobulinemia
- 31 July 1993
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 95 (1) , 49-52
- https://doi.org/10.1016/0002-9343(93)90231-d
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study.Journal of Clinical Oncology, 1992
- Fludarabine phosphate for the treatment of low grade lymphoid malignancyBritish Journal of Cancer, 1991
- Waldenström's Macroglobulinemia: Long-Term Results with the M-2 ProtocolCancer Investigation, 1991
- Fludarabine therapy in macroglobulinemic lymphomaBlood, 1990
- Waldenström's macroglobulinaemia: results of a combined oral treatment in 34 newly diagnosed patientsJournal of Internal Medicine, 1989
- Fludarabine: a new agent with major activity against chronic lymphocytic leukemiaBlood, 1989
- Recombinant interferon gamma in hairy cell leukemia, multiple myeloma, and Waldenstrom's macroglobulinemiaAmerican Journal of Hematology, 1988
- TREATMENT OF RESISTANT WALDENSTROM'S MACROGLOBULINEMIA WITH HIGH DOSE GLUCOCORTICOSTEROIDSAustralian and New Zealand Journal of Medicine, 1988
- Treatment of plasma cell neoplasm with recombinant leukocyte A interferon and human lymphoblastoid interferonCancer Chemotherapy and Pharmacology, 1985
- Successful doxorubicin therapy of primary macroglobulinemia resistant to alkylating agentsAmerican Journal of Hematology, 1980